BTN3A1 activators belong to a specific class of chemical compounds known for their ability to modulate the activity of the Butyrophilin Subfamily 3 Member A1 (BTN3A1) protein, a key player in the immune system and cellular responses. BTN3A1 is a transmembrane protein expressed on the surface of various immune cells, particularly T cells, and it has garnered significant attention for its role in immune surveillance and antigen presentation. These activators are meticulously designed to interact with BTN3A1, influencing its function and potentially affecting its interactions with other immune-related molecules. At the molecular level, the mechanisms through which BTN3A1 activators exert their effects can be intricate, involving binding to specific domains or regions of the protein, potentially inducing conformational changes that influence its cellular signaling pathways.
The study of BTN3A1 activators is instrumental in advancing our understanding of immune system regulation and the complex interplay of molecules involved in immune responses. Researchers in this field primarily focus on elucidating the precise molecular mechanisms by which these compounds impact BTN3A1's function and their downstream effects on immune cell activation, particularly T cell responses. Understanding the role of BTN3A1 activators contributes to our broader knowledge of immunology and the intricate mechanisms that govern immune recognition and surveillance. Furthermore, these compounds serve as invaluable tools for scientists seeking to investigate the molecular basis of immune responses and their implications in various physiological and pathological contexts, ultimately deepening our understanding of immune system regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Affects gene expression during immune cell differentiation; might influence BTN3A1 expression. | ||||||
Thymosin β4 | 77591-33-4 | sc-396076 sc-396076A | 1 mg 100 mg | $134.00 $7140.00 | ||
Regulates various immune processes; potential influence on BTN3A1. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $92.00 $256.00 | 5 | |
Bisphosphonate that can lead to accumulation of IPP; might indirectly influence BTN3A1 expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C; might influence BTN3A1 in the context of T-cell activation. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Calcium ionophore; potential co-stimulatory effects on T cells influencing BTN3A1 expression. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Immunosuppressant that might downregulate BTN3A1 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Immunosuppressant that inhibits mTOR; potential effects on BTN3A1 expression. | ||||||